11/14/2024
5:40 AM | Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/08/2024
3:20 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/06/2024
6:22 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
6:00 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/16/2024
5:46 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
12:49 PM | Immunocore (Subject)
T. Rowe Price Investment Management, Inc. (Filed by)
| Form SC 13G | |
|
08/29/2024
6:21 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:21 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
6:06 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/30/2024
4:22 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/29/2024
3:43 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/29/2024
3:46 PM | Immunocore (Issuer)
KRISHANA RANJEEV (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/28/2024
3:17 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
3:15 PM | Bell John Irving (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Herbst Roy Steven (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Immunocore (Issuer)
Peterson Kristine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
3:15 PM | Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
3:50 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:13 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
6:00 AM | Immunocore (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/12/2024
3:34 PM | Immunocore (Filer)
| Form ARS | |
04/05/2024
3:35 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2024
3:34 PM | Immunocore (Filer)
| Form 424B7 | |
04/02/2024
3:45 PM | Immunocore (Filer)
| Form PRE 14A | |
04/01/2024
11:36 AM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
7:51 PM | Immunocore (Filer)
| Form S-3ASR | |
03/20/2024
7:55 PM | Immunocore (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2024
7:19 AM | FMR LLC (Filed by)
Immunocore (Subject)
| Form SC 13G | |
03/07/2024
8:45 PM | GENERAL ATLANTIC, L.P. (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
02/28/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2024
3:19 PM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
6:33 AM | Immunocore (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/26/2024
5:46 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:15 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:15 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:16 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
6:57 AM | Immunocore (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/06/2024
10:00 AM | Immunocore (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
Tesla Execs are Freaking Out (Ad) It’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it.
And Elon Musk has completely restructured Tesla to chase this opportunity.
This is a once-in-a-lifetime opportunity that you don’t want to miss. Click here to get the details. |
02/01/2024
4:25 PM | BAKER BROS. ADVISORS LP (Filed by)
Immunocore (Subject)
| Form SC 13D/A | |
01/05/2024
3:17 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
6:19 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:55 PM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/02/2024
3:51 PM | Immunocore (Issuer)
Jallal Bahija (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:52 PM | Immunocore (Issuer)
Kaul Siddharth (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:53 PM | Immunocore (Issuer)
PEREZ ROBERT J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:54 PM | Immunocore (Issuer)
Peterson Kristine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:55 PM | Immunocore (Issuer)
Ratcliffe Peter John (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:57 PM | Immunocore (Issuer)
St Leger Tina Amber (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:41 PM | Di Donato Brian (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:42 PM | Bell John Irving (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:43 PM | Berman David M (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:45 PM | Coy Travis Alan (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
3:47 PM | GOLL JOHN (Reporting)
Immunocore (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/02/2024
5:25 AM | Immunocore (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/27/2023
4:30 PM | Immunocore (Subject)
Jallal Bahija (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/20/2023
12:54 PM | Immunocore (Subject)
St Leger Tina Amber (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/30/2023
7:33 PM | Berman David M (Reporting)
Immunocore (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
